Editas Medicine (NASDAQ:EDIT) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Editas Medicine beat estimated earnings by 5.81%, reporting an EPS of $-0.81 versus an estimate of $-0.86.

Revenue was down $6.16 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 2.46% increase in the share price the next day.

Here's a look at Editas Medicine's past performance:

To track all earnings releases for Editas Medicine visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.